Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
Amgen (AMGN) Gains But Lags Market: What You Should Know
10:15pm, Tuesday, 19'th Apr 2022 Zacks Investment Research
Amgen (AMGN) closed at $253.37 in the latest trading session, marking a +0.57% move from the prior day.
Amgen (AMGN) Earnings Expected to Grow: What to Know Ahead of Q1 Release
07:00pm, Tuesday, 19'th Apr 2022 Zacks Investment Research
Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amgen (AMGN) Earnings Expected to Grow: What to Know Ahead of Q1 Release
04:33pm, Tuesday, 19'th Apr 2022
Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here are 30 stocks that Goldman Sachs likes when the economy stutters and markets gyrate
02:00pm, Tuesday, 19'th Apr 2022 MarketWatch
What should investors do as the global economy swirls? Goldman Sachs says go for stable stocks, like Johnson & Johnson, Domino's Pizza and Alphabet.
Amgen's (AMGN) Stelara Biosimilar Meets Psoriasis Study Goal
01:15pm, Tuesday, 19'th Apr 2022 Zacks Investment Research
Initial data from a late-stage study comparing Amgen's (AMGN) Stelara biosimilar candidate with the original Stelara drug showed no clinically meaningful differences in treating plaque psoriasis.
Amgen's (AMGN) Stelara Biosimilar Meets Psoriasis Study Goal
10:32am, Tuesday, 19'th Apr 2022
Initial data from a late-stage study comparing Amgen's (AMGN) Stelara biosimilar candidate with the original Stelara drug showed no clinically meaningful differences in treating plaque psoriasis.
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?
10:20am, Tuesday, 19'th Apr 2022 Zacks Investment Research
Sector ETF report for PBE
Want to Invest Your Tax Refund? 3 Long-Term Stocks to Consider
06:30am, Tuesday, 19'th Apr 2022
Here are three of the best long-term stocks to invest in with tax refunds this year The post Want to Invest Your Tax Refund? 3 Long-Term Stocks to Consider appeared first on InvestorPlace.
How This Income Method Could Make You Financially Independent
01:30pm, Saturday, 16'th Apr 2022 Seeking Alpha
We discuss how a diversified income portfolio with an in-built hedging mechanism with low volatility could make you financially independent. We provide five income strategies.
3 Biotech Stocks That Could Help Make You a Fortune
10:00am, Thursday, 14'th Apr 2022 The Motley Fool
Their products could deliver major revenue over time.
Mirati: Can Adagrasib Beat Amgen's Lumakras?
02:56pm, Wednesday, 13'th Apr 2022
Mirati has a PDUFA on December 14. Lumakras is already approved conditionally, with confirmatory data this year.
Dividend Income Update March 2022
03:31am, Monday, 11'th Apr 2022
The start of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated.
Our Family Investments: March Transactions
01:39pm, Wednesday, 06'th Apr 2022
General Electric was sold. Amgen was purchased. Boeing was purchased in Jacob's account.
Top Analysts Say 8 Q1 Underperforming Dividend Stocks Could Be Huge Q2 Winners
07:15am, Tuesday, 05'th Apr 2022
After the first down quarter since 2020, many across Wall Street are examining the winners and losers for the quarter and shuffling the deck, looking for stocks that have the best upside potential for
3 Biotech Stocks to Buy in April
06:10am, Sunday, 03'rd Apr 2022
They're good picks for very different reasons.
